Efficacy and safety of pulsatile GnRH pump therapy in male infants with congenital hypogonadotropic hypogonadism
Pulsatile gonadotropin-releasing hormone pump therapy can increase penile length, testicular volume, anti-Müllerian hormone levels and serum inhibin B levels in infants with congenital hypogonadotropic hypogonadism without adverse effects. However, its long-term efficacy and safety require further follow-up.
Authors
- Dongxia Fu (ORCID: https://orcid.org/0000-0002-3591-4422)
- Mengmeng Du (ORCID: https://orcid.org/0000-0001-6156-1491)
- Zixia Zhang
- Jiajia Chen (ORCID: https://orcid.org/0000-0002-2068-509X)
- Xi Wang (ORCID: https://orcid.org/0000-0002-7572-6354)
- Haiyan Wei (ORCID: https://orcid.org/0000-0003-1044-6594)
- Yongxing Chen (ORCID: https://orcid.org/0000-0002-4131-137X)
Institutions
- Capital Medical University (CN)
- Zhengzhou Children's Hospital (CN)
- Beijing Children’s Hospital (CN)
Publication Details
- Journal
- Endocrine Connections
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1530/ec-24-0655
- Primary Topic
- Sexual Differentiation and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00